Status:
COMPLETED
The Value of Using Colostrum Supplements on the Physical Performance and Cognitive Function in Healthy Subjects and Type 2 Diabetes
Lead Sponsor:
Al-Rasheed University College
Collaborating Sponsors:
Al-Farabi Kazakh National University
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
The goal of this interventional Randomized clinical is to compare the effect of colostrum pharmaceutical preparation and placebo in a sample of Iraqi participants. The main questions to answer are: 1...
Eligibility Criteria
Inclusion
- Apperantly Healthy patients for control
- Patients diagnosed with T2DM
- Age between 18-70
Exclusion
- Patients with T1DM
- Patients with a drug history of anabolic substances for more than 14 days duration.
- Patients with co-morbidities (e.g. CVS, renal, hepatic, and endocrine disorders)
- Pregnancy, lactation, or female patient willing for conception.
Key Trial Info
Start Date :
August 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 10 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06549556
Start Date
August 20 2024
End Date
December 10 2024
Last Update
December 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Al-Zahraa Teaching Hospital
Wāsiţ, Iraq, 52001